Emanuela Senjor
Ljubljana, 1000, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Glioblastoma-natural killer cell crosstalk: insights from dynamic spheroid models reveal the importance of secreted cytokines and the CD155 axis.
Journal: Cell communication and signaling : CCS
Published: October 29, 2025
Targeting cystatin F activation enhances NK cell cytotoxicity in glioblastoma models.
Journal: Frontiers in immunology
Published: September 18, 2025
Exhausted natural killer cells in adult IgA vasculitis.
Journal: Arthritis research & therapy
Published: February 06, 2025
Osteoclast-expanded supercharged NK cells perform superior antitumour effector functions.
Journal: BMJ oncology
Published: January 29, 2025
Different glycosylation profiles of cystatin F alter the cytotoxic potential of natural killer cells.
Journal: Cellular and molecular life sciences : CMLS
Published: May 23, 2023
Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders.
Journal: Biomedicines
Published: December 31, 2022
Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice.
Journal: Frontiers in immunology
Published: December 27, 2022
New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity.
Journal: Computational and structural biotechnology journal
Published: May 20, 2022
Probiotics in Health and Disease: Distinct Roles of Different Strains in Natural Killer Cell Activation and Regulation.
Journal: Critical reviews in immunology
Published: August 04, 2021
Cystatin F acts as a mediator of immune suppression in glioblastoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: June 03, 2021
Last Updated: 09/26/2026